Price
Financials
Standalone, Rs crore| Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.11 | 1.17 | 1.53 | 1.71 | 0.43 | 0.40 | 0.86 | 0.23 | 58.01 | 281.05 | 515.53 | 3.99 |
| Expenses | 7.05 | 1.04 | 0.32 | 2.37 | 1.38 | 0.34 | -0.44 | 0.47 | 56.88 | 275.79 | 511.64 | 3.05 |
| Operating Profit | 0.06 | 0.13 | 1.21 | -0.66 | -0.95 | 0.06 | 1.30 | -0.24 | 1.13 | 5.26 | 3.89 | 0.94 |
| OPM % | 0.84% | 11.11% | 79.08% | -38.60% | -220.93% | 15.00% | 151.16% | -104.35% | 1.95% | 1.87% | 0.75% | 23.56% |
| Other Income | 0.00 | 1.40 | 0.00 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.00 |
| Interest | 0.00 | 0.14 | 0.15 | 0.26 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.04 | 1.36 | 1.03 | -0.28 | -0.98 | 0.04 | 1.30 | -0.24 | 1.13 | 5.26 | 3.89 | 9.94 |
| Tax % | 0.00% | 0.00% | 74.76% | 0.00% | -11.22% | 0.00% | 10.00% | 0.00% | 19.47% | 23.76% | 26.74% | 25.15% |
| Net Profit | 0.04 | 1.37 | 0.26 | -0.28 | -0.87 | 0.04 | 1.17 | -0.24 | 0.90 | 4.01 | 2.85 | 7.44 |
| EPS in Rs | 0.00 | 0.02 | 0.00 | -0.00 | -0.01 | 0.00 | 0.02 | -0.00 | 0.00 | 0.02 | 0.01 | 0.04 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9 | 19 | 23 | 35 | 51 | 55 | 41 | 21 | 14 | 3 | 855 | 859 |
| Expenses | 9 | 18 | 23 | 34 | 47 | 54 | 49 | 25 | 13 | 4 | 845 | 847 |
| Operating Profit | 0 | 1 | 0 | 2 | 3 | 1 | -8 | -4 | 1 | -0 | 10 | 11 |
| OPM % | 2.4% | 2.8% | 1.8% | 4.4% | 7% | 2.2% | -19% | -21% | 7% | -15% | 1.2% | 1.3% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 2 | 9 | 8 | 2 | 1 | 0 | 9 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 3 | 3 | 0 | 10 | 20 |
| Tax % | 31% | 44% | 33% | 27% | 27% | 26% | 25% | 28% | 29% | 29% | 25% | |
| Net Profit | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 0 | 8 | 15 |
| EPS in Rs | 0.07 | 0.11 | 0.23 | 0.42 | 0.02 | 0.00 | 0.02 | 0.02 | 0.00 | 0.04 | 0.07 | |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 58% | 73% | 244% | 44618% | ||
| Compounded Profit Growth | 53% | 33% | 50% | 15100% | ||
| Stock Price CAGR | % | -53% | -23% | -68% | ||
| Return on Equity | 7% | 5% | 5% | 6% |
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.11 | 0.11 | 0.31 | 0.31 | 6 | 6 | 12 | 12 | 49 | 186 |
| Reserves | 0 | 1 | 1 | 1 | 5 | 6 | 8 | 8 | 4 | 6 | 6 | 23 |
| Borrowings | 0 | 1 | 2 | 2 | 7 | 10 | 9 | 11 | 9 | 9 | 0 | 213 |
| Other Liabilities | 0 | 3 | 6 | 7 | 7 | 8 | 12 | 2 | 3 | 1 | 64 | 231 |
| Total Liabilities | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 5 | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | 120 | 652 |
| Total Assets | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0 | -2 | -0 | 0 | -7 | -0 | -3 | -7 | 3 | 0 | -16 | -323 |
| Cash from Investing Activity | 0 | -0 | -0 | -0 | -0 | -0 | -3 | 3 | 0 | 0 | -0 | -0 |
| Cash from Financing Activity | 0 | 2 | 1 | -0 | 7 | 1 | 7 | 3 | -3 | -0 | 28 | 358 |
| Net Cash Flow | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -1 | -0 | -0 | 12 | 35 |
| Free Cash Flow | 0 | -2 | -0 | 0 | -7 | -0 | -4 | -7 | 3 | 0 | -16 | -323 |
| CFO/OP | -857% | -39% | 40% | -431% | 4% | -227% | 91% | -59% | 28% | 3,560% | -3,220% |
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 125 | 87 | 56 | 111 | 78 | 112 | 95 | 261 | 217 | 1,225 | 108 | |
| Inventory Days | 71 | 78 | 108 | 91 | 86 | 97 | 122 | 179 | 392 | 1,439 | 1 | |
| Days Payable | 113 | 107 | 83 | 77 | 54 | 83 | 10 | 18 | -25 | 7 | 85 | |
| Cash Conversion Cycle | 82 | 58 | 82 | 125 | 111 | 126 | 207 | 422 | 635 | 2,657 | 24 | |
| Working Capital Days | 81 | 24 | 34 | 64 | 57 | 79 | 143 | 279 | 472 | 5,034 | 160 | |
| ROCE % | 0% | 22% | 21% | 22% | 25% | 24% | 17% | 4% | 12% | 12% | 1% | 4% |
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 99.99% | 99.99% | 99.99% | 100.01% | 100.00% | 100.00% | 100.01% | 100.00% | 100.00% | 100.01% | 100.00% | 99.99% |
| No. of Shareholders | 31,093 | 30,714 | 31,603 | 48,146 | 52,415 | 58,634 | 55,791 | 54,654 | 62,098 | 78,899 | 1,15,958 | 1,33,664 |
Fundamentals
Market Cap₹ 38.8 Cr.
Current Price₹ 0.19
Stock P/E2.56
Book Value₹ 1.02
ROCE4.20 %
ROE5.69 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)44618%
Compounded Profit Growth (TTM)15100%
Standalone figures.
Valuation
P/E, 3-year average108.86x
P/B, 3-year average0.28x
P/E, 5-year average70.33x
P/B, 5-year average0.34x
Profitability
Operating margin (excl. other income)1.17%
Operating margin (incl. other income)1.17%
EBITDA margin2.36%
Pre-tax margin2.36%
Net profit margin1.77%
Net margin, latest quarter186.47%
ROE5.69%
ROCE4.20%
ROA1.95%
ROE, 3-year average5.67%
ROCE, 3-year average5.56%
ROA, 3-year average2.97%
ROE, 5-year average6.37%
ROCE, 5-year average6.65%
ROA, 5-year average3.41%
ROIC (approx.)4.05%
Tax rate25.02%
Growth
Sales growth (latest year)26613.12%
Profit growth (latest year)14940.00%
Sales CAGR, 3 years243.78%
Sales CAGR, 5 years73.03%
Profit CAGR, 3 years50.18%
Profit CAGR, 5 years32.81%
Sales growth QoQ-99.23%
Profit growth QoQ161.05%
Sales growth YoY (latest quarter)1634.78%
Per share
EPS (TTM)Rs 0.07
EPS (latest year)Rs 0.08
EPS (latest quarter)Rs 0.04
EPS, 3-year averageRs 0.13
EPS, 5-year averageRs 0.18
Book value per shareRs 1.02
Sales per shareRs 4.20
Cash flow per shareRs -1.58
Free cash flow per shareRs -1.58
Efficiency
Asset turnover1.31x
Inventory turnover533.67x
Inventory days1 days
Debtor days108 days
Debtors turnover3.39x
Creditor days85 days
Cash conversion cycle24 days
Working capital days160 days
Leverage
Total debtRs 213 Cr
Cash and bankRs 47 Cr
Net debtRs 166 Cr
Debt to equity1.02x
Net debt / EBITDA8.22x
Owners' fund to total sources31.98%
Debt to assets32.63%
Cash flow
Cash from Operating Activity (latest year)Rs -323 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs 358 Cr
Net Cash Flow (latest year)Rs 35 Cr
Free cash flow (latest year)Rs -323 Cr
FCFE (approx.: FCF + change in debt)Rs -110 Cr
Cash from ops / profit, 5 years-28.58x
Statement figures
Net sales (TTM)Rs 859 Cr
Net sales (latest year)Rs 855 Cr
Sales (latest quarter)Rs 4 Cr
Operating profit excl. other income (latest year)Rs 10 Cr
Operating profit (latest quarter)Rs 1 Cr
EBITDA (TTM)Rs 20 Cr
PBDT (TTM)Rs 20 Cr
Profit before tax (TTM)Rs 20 Cr
Tax (latest year)Rs 3 Cr
Net profit (TTM)Rs 15 Cr
Net profit (latest year)Rs 8 Cr
Net profit (latest quarter)Rs 7 Cr
Cost of goods sold (latest year)Rs 843 Cr
Total expenditure (latest year)Rs 845 Cr
Total income (latest year)Rs 855 Cr
Share capitalRs 186 Cr
ReservesRs 23 Cr
Shareholders' fundsRs 208 Cr
Total assetsRs 652 Cr
ReceivablesRs 252 Cr
InventoryRs 2 Cr
Other liabilitiesRs 231 Cr
Shares outstanding (crore)204.47
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 2.6 is the lowest in its own 4.8-year history
(median 93.0, low 2.6, high 369.6).
P/B 0.19 is the lowest in 6.5 years (median 11.61).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Not enough price history.
Red flags
F-score 4 of 8| explain | Weak cash conversion Cash from operations was -3546% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 51% of total assets in 2025 |
| explain | Share dilution Share count up 182% in a year, 126% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2025Sales ₹4 Cr +1634.8% vs Jun 2024.
Net profit ₹7 Cr +3200.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Murae Organisor Ltd?
Murae Organisor Ltd (542724) has a market capitalisation of Rs 38.8 Cr. at the close.
What is the P/E ratio of Murae Organisor Ltd?
Murae Organisor Ltd trades at a P/E of 2.56 on trailing twelve-month profit, at the close.
What were Murae Organisor Ltd's latest quarterly results?
In the Jun 2025 quarter, Murae Organisor Ltd sales was Rs 4 Cr (+1634.8% vs Jun 2024) and net profit was Rs 7 Cr.